Navigation Links
MiMedx Group Announces Record First Quarter Results
Date:5/2/2012

KENNESAW, Ga., May 2, 2012 /PRNewswire/ -- MiMedx Group, Inc.  (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter  ended March 31, 2012.

  • Revenue Increases over 250%
  • Positive Adjusted EBITDA* Achieved for the First Time in Company History
  • Company Achieves Another Reimbursement Milestone for EpiFix®
  • Highlights of First Quarter 2012 ResultsThe Company recorded record revenue for the first quarter of 2012, with revenue of $3.7 million, a 255% or $2.7 million increase over first quarter of 2011 revenue of $1.0 million, and a 41% increase over fourth quarter of 2011 revenue of $2.6 million.  The Company's earnings before interest, taxes, depreciation, amortization and share-based compensation (Adjusted EBITDA*) for the quarter ended March 31, 2012, were a record high of $314,000, a $2.6 million improvement as compared to the Adjusted EBITDA loss of $2.3 million for the first quarter of 2011. The Company also reported record gross margins for the quarter.

    Management Commentary on First Quarter ResultsParker H. "Pete" Petit, Chairman and CEO, stated, "We have worked diligently to achieve positive EBITDA for the first quarter. This is a very important milestone for our shareholders, and we are very pleased that we have passed the threshold into positive EBITDA, which is a signal that we are approaching positive cash flow.  Our first quarter results were driven not only by increased revenue, but also by dramatically improved gross margins and reduced spending in research and development. Our reported gross margins for the first quarter were 74%, more than a twofold improvement over 2011 gross margins of 32%.  Sales in the wound care, spine and orthopedics/sports medicine markets were
    '/>"/>

    SOURCE MiMedx Group, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related biology technology :

    1. MiMedx Group Announces Temporary Trading Symbol Designation
    2. MiMedx Group, Inc. to Present at Noble Financial Sixth Annual Equity Conference
    3. MiMedx Group, Inc. Announces Release Date For Third Quarter Results
    4. MiMedx Group, Inc. to Present at the 13th Annual Needham Growth Conference
    5. MiMedx to Attend American Academy of Orthopedic Surgeons Annual Meeting
    6. MiMedx Announces Launch of AmnioFix™
    7. MiMedx Group, Inc. to Present at the 10th Annual Needham Healthcare Conference
    8. MiMedx Group Announces 2010 Results
    9. MiMedx Group Announces First Quarter 2011 Results
    10. MiMedx Group, Inc. to Present at the Noble Financial Capital Markets Seventh Annual Equity Conference
    11. MiMedx Group Completes $5,000,000 Private Placement
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/30/2014)... Jose, California (PRWEB) September 30, 2014 ... measure the level of each type of cholesterol carrier ... since the presence of excessive cholesterol levels in the ... a precursor condition to heart attack and other cardiovascular ... fatality worldwide, therefore testing for cholesterol levels on a ...
    (Date:9/30/2014)... 2014 Genedata, a leading ... discovery and related life science research, today ... Genedata Selector as its host-pathogen data analysis ... is a European consortium dedicated to improving ... individualized anti-fungal drug therapies. Genedata Selector supports ...
    (Date:9/30/2014)... 2014 FemCap Inc., www.femcap.com  an innovator ... of a patent No: US, 8,795,248 B2 dated Aug. ... FDA clearance in the U.S., 510(K) K121857, medical device ... patent is related to its menstrual cup with a ... is releasing FemmyCycle Teen, a third menstrual cup to ...
    (Date:9/30/2014)... September 30, 2014 Lyme Research ... of Lyme disease research at universities, today announced the ... on the identification, treatment and cure for Lyme and ... received the most applications in its history—over 20 grant ... “While we were pleased to receive so many solid ...
    Breaking Biology Technology:Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 2Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 3Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 4FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3The FemmyCycle 2Lyme Research Alliance Awards Nearly $600,000 in New Grants 2Lyme Research Alliance Awards Nearly $600,000 in New Grants 3Lyme Research Alliance Awards Nearly $600,000 in New Grants 4
    ... Dec. 9 The results of a new study on ... 30 sites around the country, will be published in the ... Salloway, MD, MS, director of the Butler Hospital Memory and ... the Warren Alpert Medical School of Brown University, says that ...
    ... , SAN DIEGO, Dec. 9 ... life-saving medicines specifically designed to enhance the perfusion and ... and other gas delivery, today announced that the European ... MP4CO for the treatment of sickle cell disease. This ...
    ... ... Platform for High Throughput and High Content Screening. , ... Basel, Switzerland and Granada, Spain (PRWEB) December 8, ... discovery and life science research, and Fundación MEDINA (Centro de Excelencia en ...
    Cached Biology Technology:Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease 2Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 2Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 3MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 2MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 3MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 4
    (Date:9/30/2014)... think of nature as something that we enjoy when we ... Or do we think of ourselves as a part of ... what about a house? , The answers to these ... our actions, our speech and in cultural artifacts. , A ... Washington, the American Indian Center of Chicago and the Menominee ...
    (Date:9/30/2014)... WASHINGTON, D.C., September 30, 2014--Sea monkeys have captured the ... of their easily observable life cycle -- sold as ... and mate given little more than a tank of ... a shorter-term pattern: Like other zooplankton, brine shrimp vertically ... conditions, coming closer to the surface at night and ...
    (Date:9/30/2014)... engineers, led by Clemson University associate professor Brian ... from the U.S. Department of Energy,s Experimental Program ... positive impact on South Carolina in the advancement ... , "Understanding the scientific and engineering needs for ... nuclear technologies is imperative if South Carolina is ...
    Breaking Biology News(10 mins):The cultural side of science communication 2Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents 2Researchers get $5.25 million to advance nuclear technologies in South Carolina 2
    ... anywhere, a researcher at the Hebrew University of Jerusalem has ... the brain of a mammal. , Dr. Adi Mizrahi ... of Life Sciences at the Hebrew University, used mouse models ... undifferentiated cellular sphere into a rich and complex cell. This ...
    ... cure type 1 diabetes by allowing people to ... defective pancreas, medical researchers here have reported that they ... cord blood to produce insulin. , The researchers announced ... research, in the June 2007 issue of the medical ...
    ... organism that produces the world’s most lethal toxin is revealed today. ... Clostridium botulinum and less than 2 kg — the weight of ... on the planet. Very small amounts of the same toxin are ... , The genome sequence shows that C. botulinum doesn’t have subtle ...
    Cached Biology News:A first -- Hebrew University scientist observes brain cell development in 'real time' 2Adult stem cells from human cord umbilical cord blood successfully engineered to make insulin 2Adult stem cells from human cord umbilical cord blood successfully engineered to make insulin 3Genome of Clostridium botulinum reveals the background to world's deadliest toxin 2Genome of Clostridium botulinum reveals the background to world's deadliest toxin 3
    ... Immunogen: synthetic peptide corresponding to the ... dopamine receptor, conjugated to KLH. The ... rat and mouse gene. Physical form: ... containing 0.01% sodium azide. Titertest method: ...
    ... The National Collection of Pathogenic ... authenticated human pathogenic viruses in ... is able to supply the ... from them, to the scientific ...
    ... The flexible and easy ... used to control all members ... family. It features a clear ... visual assay setup, user-friendly and ...
    Roll of Mesh 5m x 25cm...
    Biology Products: